INNOVATE BIOPHARMACEUTICALS, INC.
INNOVATE BIOPHARMACEUTICALS, INC. (INNT) is a publicly traded company in the Unknown sector. Across all available filings, 8 corporate insiders have executed 43 transactions totaling $624.2K, demonstrating a bullish sentiment with $624.2K in net insider flow. The most recent transaction on Jun 28, 2019 involved a purchase of 4,000 shares valued at $4.6K.
INNT Insider Activity Summary
Who Is Buying INNT Stock?
No significant insider buying has been recorded for INNT in the recent period.
Who Is Selling INNT Stock?
No significant insider selling has been recorded for INNT in the recent period.
Is INNOVATE BIOPHARMACEUTICALS, INC. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INNT is bullish with an Insider Alignment Score of 100/100 and a net flow of $624.2K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
INNT Frequently Asked Questions
Understanding INNT Insider Activity
Insider trading at INNOVATE BIOPHARMACEUTICALS, INC. (INNT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 8 insiders are actively trading INNT stock, having executed 43 transactions in the past 90 days. The most active insider is David H. Clarke (Executive), who has made 11 transactions totaling $542.3K.
Related Tools
Track INNOVATE BIOPHARMACEUTICALS, INC. Insider Activity
Get notified when executives and directors at INNT file new Form 4 transactions